GC녹십자엠에스, 중국 유웰과 맞손
Predicted impact: Low· Actual: −3.9% vs sector, volume 2.1× normal (5 trading days)
Partnership to introduce Chinese glucose monitor; small company, already reported in last 14 days.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.